Literature DB >> 17196822

Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.

Mariano García-Yuste1, José M Matilla, Antonio Cueto, José Manuel Rodríguez Paniagua, Guillermo Ramos, Miguel Angel Cañizares, Ignacio Muguruza.   

Abstract

BACKGROUND: This study examines the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung with patients treated surgically for typical and atypical carcinoid tumours.
METHODS: From 1980 to 2002, 661 patients were treated surgically for 569 typical carcinoid tumours and 92 atypical carcinoid tumours. Three hundred and four cases were studied retrospectively from 1980 to 1997 (261 typical carcinoid and 43 atypical carcinoid tumours); the other 357 new cases (308 typical carcinoid and 49 atypical carcinoid tumours) were collected prospectively from 1998 to 2002. Tumours were classified according the 1999 classification from the WHO and the International Association for the Study of Lung Cancer (IASLC). Several variables were reviewed in all patients. Univariate and multivariate statistical analyses were performed in order to determine whether clinical characteristics were associated with significant differences in survival.
RESULTS: In the total of the patients, 5-year survival for different tumours was as follows: typical carcinoid: overall survival 97%; with nodal involvement 100%; atypical carcinoid: overall 78%; with nodal involvement 60%. A significant difference in survival was found between patients in the retrospective and prospective groups with atypical carcinoid and nodal involvement. The comparative analysis of several factors in typical and atypical carcinoid tumours showed a significant difference for mean age, tumour size, nodal involvement and distant metastases.
CONCLUSION: Nodal involvement and histological sub-type appear as the most important factors influencing the prognosis. Adequate lung resection and systematic radical mediastinal lymphadenectomy should always be performed. Sleeve resection could be performed in central typical and atypical carcinoid tumours, avoiding pneumonectomy.

Entities:  

Mesh:

Year:  2006        PMID: 17196822     DOI: 10.1016/j.ejcts.2006.11.031

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  43 in total

Review 1.  Pathologic research update of colorectal neuroendocrine tumors.

Authors:  Shu-Juan Ni; Wei-Qi Sheng; Xiang Du
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

2.  In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines.

Authors:  Wolfgang Fiebiger; Ulrike Olszewski; Ernst Ulsperger; Klaus Geissler; Gerhard Hamilton
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

Review 3.  Multidisciplinary management of advanced lung neuroendocrine tumors.

Authors:  Pier Luigi Filosso; Piero Ferolla; Francesco Guerrera; Enrico Ruffini; William D Travis; Giulio Rossi; Paolo Olivo Lausi; Alberto Oliaro
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 4.  Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.

Authors:  Giuseppe Pelosi; Mauro Papotti; Guido Rindi; Aldo Scarpa
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

Review 5.  Carcinoid tumors.

Authors:  Scott N Pinchot; Kyle Holen; Rebecca S Sippel; Herbert Chen
Journal:  Oncologist       Date:  2008-12-17

6.  Clinical outcomes of atypical carcinoid tumors of the lung and thymus: 7-year experience of a rare malignancy at single institute.

Authors:  Boram Han; Jong-Mu Sun; Jin Seok Ahn; Keunchil Park; Myung-Ju Ahn
Journal:  Med Oncol       Date:  2013-02-03       Impact factor: 3.064

7.  Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors.

Authors:  Curtis R Chong; Lori J Wirth; Mizuki Nishino; Aileen B Chen; Lynette M Sholl; Matthew H Kulke; Ciaran J McNamee; Pasi A Jänne; Bruce E Johnson
Journal:  Lung Cancer       Date:  2014-08-27       Impact factor: 5.705

Review 8.  Advances on systemic treatment for lung neuroendocrine neoplasms.

Authors:  Nikolaos Tsoukalas; Panagiotis Baxevanos; Eleni Aravantinou-Fatorou; Maria Tolia; Michail Galanopoulos; Konstantinos Tsapakidis; George Kyrgias; Christos Toumpanakis; Gregory Kaltsas
Journal:  Ann Transl Med       Date:  2018-04

9.  Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.

Authors:  Kevin L Anderson; Michael S Mulvihill; Paul J Speicher; Babatunde A Yerokun; Brian C Gulack; Daniel P Nussbaum; David H Harpole; Thomas A D'Amico; Mark F Berry; Matthew G Hartwig
Journal:  Ann Thorac Surg       Date:  2017-07-29       Impact factor: 4.330

10.  Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.

Authors:  Giacomo Cusumano; Ludovic Fournel; Salvatore Strano; Diane Damotte; Marie Christine Charpentier; Antonio Galia; Alberto Terminella; Maurizio Nicolosi; Jean Francois Regnard; Marco Alifano
Journal:  Lung       Date:  2017-10-11       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.